首页
登录
职称英语
Celebrate. Celebrate. Physicians are delighted with a Food and Drug Administ
Celebrate. Celebrate. Physicians are delighted with a Food and Drug Administ
游客
2025-01-22
9
管理
问题
Celebrate. Celebrate. Physicians are delighted with a Food and Drug Administration(FDA)advisory panel’s recommendation earlier this year that Vioxx and its cousins Bextra and Celebrex(all medicines known as Cox-2 inhibitors)should remain on the market, despite evidence they increase heart disease risk in some people. The panelists reached their decision after weighing all the data and concluding the benefits of these pain-relieving drugs outweighed the risks.
Specifically, these scientists acknowledged that, for some patients, these prescription drugs were uniquely effective in reducing pain from arthritis and other causes. For others—concerned about ulcers associated with aspirin and other OTC analgesics—the Cox-2 inhibitors offered the advantage of minimizing potentially serious effects of stomach irritation.
Now is an appropriate time for everyone to take a fresh look at the benefit-risk equation for Vioxx and the other Cox-2 inhibitors.
The risks— increased risk of heart disease in some who use the drugs—have been well publicized. Much less publicity has been given to a spectrum of real and potential benefits that go way beyond reduced risk of stomach irritation. These little-discussed benefits would have been lost, perhaps permanently-had Vioxx, Bextra and Celebrex been driven from shelves in pursuit of perfect safety, an unattainable goal.
For example, there is substantial evidence Cox-2 inhibitors can reduce development of colon polyps, which may become colon canceL Indeed. Celebrex is FDA-approved for those genetically prone to colon cancer. Ironically, the 2004 study that revealed the elevated heart attack risk of Vioxx was primarily designed to further establish the drug’s effectiveness in protecting against colon cancer. And while the results of that interrupted trial have not yet been published, there is good reason to believe they will confirm the protective effects against colon cancer established in research over the last 10 years.
At the time of its withdrawal from the market last fall, studies of Vioxx as well as the other Cox-2 drugs suggest that they had other anti-cancer properties as well, possibly reducing the risk of malignancies of a number of sites, including the lung and esophagus.
Had these drugs been dismissed, their untapped promise for prevention would have evaporated well before it was evaluated and applied to save lives. Fortunately, cooler and wiser heads prevailed. [br] The word "unattainable" underlined in Paragraph 4 is closest in meaning to______.
选项
A、unrealizable
B、undoable
C、unachievable
D、impossible
答案
A
解析
根据文中第四段的内容“in pursuit of perfect safety,an unattainable goal”可知,为了追求完美的安全,也就是一个无法完成的目标。选项中的A项为“无法实现的”符合文意。B项“不能做的”,C项“不能实现的",D项“不可能的”,这三项均不符合题意。
转载请注明原文地址:https://www.tihaiku.com/zcyy/3923252.html
相关试题推荐
Iamdelightedthatweareonceagaincelebratingtheachievementsofourcol
[originaltext]Iamdelightedthatweareonceagaincelebratingtheachievem
IamdelightedtoonceagainbestandingbeforeyouaswecelebrateCanadaDa
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
Washington:TheBushadministrationhas【C1】______forthefirsttimethatit
随机试题
Likeallanimalspecies,plantspeciesmustspreadtheiroffspringtosuitab
[originaltext]Monarchbutterflies,thelargeoriginblackinsects,areaco
哪种有害金属元素中毒可引起水俣病:A.铅 B.汞 C.砷 D.镉 E.铜
各种运输方式内外部的各个方面的构成和联系,就是( )。 A.运输系统
会计报表的审计是指从审计工作开始到审计报告完成的整个过程,一般包括()。A:计划
(2020年真题)下列关于中国特色社会主义法律体系特征的表述正确的是?A.体现中
唾液腺良性肿瘤造影的特征性表现是A.导管粗细不均,呈腊肠状 B.导管移位,呈抱
在固定资产系统的下列操作中,需要进行资产变动处理的有()。A、原值增加 B、净
设备采购合同中,由( )负责提供设备运至目的地的包装。A.买方 B.卖方
下列关于行政机关实施行政强制执行的行为,表述错误的是()。A.行政机关可以与当事
最新回复
(
0
)